Medical practitioners are constantly updating and refining approaches to prostate cancer care, while new cutting-edge ...

Testing led to a 'sustained reduction' in deaths over the 23-year follow-up period, with the benefits outweighing potential ...

A Bay Area biotech company is behind a potentially groundbreaking blood test that promises to be a game-changer in cancer ...

Two cancer experts go head to head, arguing the case for and against a targeted prostate cancer screening programme.

Louise Ansari, chief executive of Healthwatch England said: “Contrary to evidence that men are reluctant to attend health services, our findings show that most men would attend a national prostate ...